Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method

Abstract The most powerful analgesic and addictive properties of opiate alkaloids are mediated by the μ opioid receptor (MOR). The MOR has been extensively investigated as a drug target in the twentieth century, with numerous compounds of varying efficacy being identified. We employed molecular dyna...

Full description

Bibliographic Details
Main Authors: Yeng-Tseng Wang, Yang-Hsiang Chan
Format: Article
Language:English
Published: Nature Publishing Group 2017-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-08224-2
id doaj-527fc220679949f9a8677f8a4f1658c3
record_format Article
spelling doaj-527fc220679949f9a8677f8a4f1658c32020-12-08T00:34:17ZengNature Publishing GroupScientific Reports2045-23222017-08-017111110.1038/s41598-017-08224-2Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics methodYeng-Tseng Wang0Yang-Hsiang Chan1Department of Biochemistry, College of Medicine, Kaohsiung Medical UniversityDepartment of Chemistry, National Sun Yat-sen University, 70 Lien Hai RoadAbstract The most powerful analgesic and addictive properties of opiate alkaloids are mediated by the μ opioid receptor (MOR). The MOR has been extensively investigated as a drug target in the twentieth century, with numerous compounds of varying efficacy being identified. We employed molecular dynamics and Gaussian accelerated molecular dynamics techniques to identify the binding mechanisms of MORs to BU72 (agonist) and β-funaltrexamine (antagonist). Our approach theoretically suggests that the 34 residues (Lys209–Phe221 and Ile301–Cys321) of the MORs were the key regions enabling the two compounds to bind to the active site of the MORs. When the MORs were in the holo form, the key region was in the open conformation. When the MORs were in the apo form, the key region was in the closed conformation. The key region might be responsible for the selectivity of new MOR agonists and antagonists.https://doi.org/10.1038/s41598-017-08224-2
collection DOAJ
language English
format Article
sources DOAJ
author Yeng-Tseng Wang
Yang-Hsiang Chan
spellingShingle Yeng-Tseng Wang
Yang-Hsiang Chan
Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
Scientific Reports
author_facet Yeng-Tseng Wang
Yang-Hsiang Chan
author_sort Yeng-Tseng Wang
title Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
title_short Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
title_full Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
title_fullStr Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
title_full_unstemmed Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
title_sort understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2017-08-01
description Abstract The most powerful analgesic and addictive properties of opiate alkaloids are mediated by the μ opioid receptor (MOR). The MOR has been extensively investigated as a drug target in the twentieth century, with numerous compounds of varying efficacy being identified. We employed molecular dynamics and Gaussian accelerated molecular dynamics techniques to identify the binding mechanisms of MORs to BU72 (agonist) and β-funaltrexamine (antagonist). Our approach theoretically suggests that the 34 residues (Lys209–Phe221 and Ile301–Cys321) of the MORs were the key regions enabling the two compounds to bind to the active site of the MORs. When the MORs were in the holo form, the key region was in the open conformation. When the MORs were in the apo form, the key region was in the closed conformation. The key region might be responsible for the selectivity of new MOR agonists and antagonists.
url https://doi.org/10.1038/s41598-017-08224-2
work_keys_str_mv AT yengtsengwang understandingthemolecularbasisofagonistantagonistmechanismofhumanmuopioidreceptorthroughgaussianacceleratedmoleculardynamicsmethod
AT yanghsiangchan understandingthemolecularbasisofagonistantagonistmechanismofhumanmuopioidreceptorthroughgaussianacceleratedmoleculardynamicsmethod
_version_ 1724396075291246592